HLA-A*32:01 and Lamotrigine-Induced DRESS—From Genetic Association to Clinical Implementation - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Genetic Link Between HLA-A*32:01 and Lamotrigine-Related DRESS: Insights for Clinical Practice

  • By

  • Kun Lin Lu

  • September 2, 2026

Share

Objective:

To examine the association between HLA-A*32:01 and lamotrigine-induced drug reaction with eosinophilia and systemic symptoms (DRESS).

Approach:
  • Study Design: Matched case-control investigation involving a predominantly White cohort from two US centers.
  • Statistical Analysis: Comparison of HLA-A*32:01 carriage between DRESS cases and lamotrigine-tolerant controls.
  • Mechanistic Insights: In silico modeling to predict lamotrigine binding to HLA-A*32:01.
Key Findings:
  • HLA-A*32:01 was present in 41.4% of DRESS cases compared to 4.1% of controls, according to the study.
  • Carriage of HLA-A*32:01 was associated with increased odds of DRESS (OR, 16.4; 95% CI, 6.4-42.5) as reported in the study.
  • Concurrent acute liver injury was observed in 69.0% of DRESS cases, but did not differ by HLA-A*32:01 status, as noted in the findings.
Interpretation:

The findings suggest a genetic association between HLA-A*32:01 and lamotrigine-induced DRESS, but the clinical utility of routine screening remains uncertain.

Limitations:
  • HLA-A*32:01 accounted for only 41.4% of DRESS cases, indicating other genetic factors may be involved, as stated in the study.
  • The study's sample size limits the ability to evaluate lower-frequency alleles, according to the authors.
Conclusion:

['The study provides preliminary evidence for HLA-A*32:01 as a risk factor for DRESS, but further validation is necessary.']

Sources:

Original Source(s)

Related Content